Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis (Q34050113)

30 July 2017

title

Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis (English)

1 reference

30 July 2017

0 references

13

Robert P Baughman

1 reference

30 July 2017

1

Nadera J Sweiss

1 reference

30 July 2017

Imre Noth

2

1 reference

30 July 2017

Mehdi Mirsaeidi

3

1 reference

30 July 2017

Wei Zhang

4

1 reference

30 July 2017

Edward T Naureckas

5

1 reference

30 July 2017

D Kyle Hogarth

6

1 reference

30 July 2017

Mary Strek

7

1 reference

30 July 2017

Philip Caligiuri

8

1 reference

30 July 2017

Roberto F Machado

9

1 reference

30 July 2017

Timothy B Niewold

10

1 reference

30 July 2017

Joe G N Garcia

11

1 reference

30 July 2017

Aileen L Pangan

12

1 reference

30 July 2017

publication date

18 April 2014

1 reference

Sarcoidosis Vasculitis and Diffuse Lung Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

31

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

46-54

1 reference

Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestry

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Disfiguring annular sarcoidosis improved by adalimumab

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Osseous sarcoidosis treated with tumor necrosis factor-inhibitors: case report and review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

A concise review of pulmonary sarcoidosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Fungal infections as a complication of therapy for sarcoidosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

A case control etiologic study of sarcoidosis: environmental and occupational risk factors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Future directions in sarcoidosis research: summary of an NHLBI working group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Perceived exertion as an indicator of somatic stress

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Tumor necrosis factor production by human sarcoid alveolar macrophages

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Endpoints for clinical trials of sarcoidosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Treatment of therapy-resistant sarcoidosis with adalimumab.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Treatment of sarcoidosis with infliximab

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

28 October 2018

Statement on Sarcoidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134103

Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept

28 October 2018

1 reference

12 December 2020

Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis

1 reference

12 December 2020

Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis

1 reference

12 December 2020

1 reference

12 December 2020

Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis

1 reference

12 December 2020

Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis

1 reference

12 December 2020

Prolonged use of methotrexate for sarcoidosis

1 reference

12 December 2020

Genetics of sarcoidosis

1 reference

12 December 2020

Identifiers

PMC publication ID

4134103

1 reference

30 July 2017

1 reference